About us Pricing ContactSubscribe

J

James G. Christensen

Pfizer (United States)ORCID https://orcid.org/0000-0003-1835-0335

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Science Translational Medicine20113,534 citations

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

Cancer Cell20091,697 citations

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

Journal of Medicinal Chemistry2011909 citations

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

Cancer Letters2004518 citationsFirst authorCorresponding

James G. Christensen · Scinovex